Clinical Trial Update: Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial [Phase 4]

View source ↗

Summary

Phase 4 safety pilot trial evaluating hydroxychloroquine for prevention of cardiovascular events in patients with myocardial infarction or acute coronary syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Myocardial Infarction, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED